Published in World J Gastroenterol on March 28, 2005
Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol (2011) 0.97
Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study. World J Surg (2011) 0.87
Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci (2007) 0.87
Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma. HPB (Oxford) (2011) 0.86
Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. World J Gastroenterol (2006) 0.85
Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors. Cancer Cell Int (2013) 0.83
Adjuvant treatment in biliary tract cancer: to treat or not to treat? World J Gastroenterol (2012) 0.83
Ruptured peripheral cholangiocarcinoma with hemoperitoneum. Dig Dis Sci (2006) 0.82
Liver transplantation for cholangiocarcinoma: Current status and new insights. World J Hepatol (2015) 0.81
Outcomes following resection of intrahepatic cholangiocarcinoma. HPB (Oxford) (2014) 0.81
Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection. Dis Markers (2015) 0.76
Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma. World J Surg (2014) 0.75
Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther (2017) 0.75
Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma. Am J Clin Oncol (2016) 0.75
Biliary tract cancers. N Engl J Med (1999) 6.36
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology (2001) 5.12
Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57
The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol (2000) 2.25
Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology (2001) 2.07
Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation (2000) 1.79
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg (2002) 1.75
Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol (1999) 1.74
Polypoid epithelial tumors of the bile ducts. N Engl J Med (1962) 1.54
Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology (2000) 1.43
A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer (2001) 1.40
The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer (1998) 1.38
Risk factors for biliary tract carcinogenesis. Ann Oncol (1999) 1.31
Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer (1995) 1.31
Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology (2002) 1.26
Factors of biliary carcinogenesis in choledochal cysts. Eur J Pediatr Surg (2001) 1.24
Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol (2004) 1.09
Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases. Ann Surg (1998) 1.06
Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg (2002) 1.05
Malignancy in choledochal cysts. Hepatogastroenterology (2000) 1.03
Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery (2002) 1.03
Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J Surg (2001) 0.99
Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders. Dig Dis Sci (2001) 0.99
Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg (2002) 0.98
Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys (1984) 0.98
Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology (1997) 0.93
Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan. J Hepatobiliary Pancreat Surg (2000) 0.92
Primary sclerosing cholangitis: a clinical review. Am J Gastroenterol (1998) 0.86
Malignancy associated with hepatolithiasis. Hepatogastroenterology (1997) 0.84
Management of hilar bile duct carcinoma. Hepatogastroenterology (2001) 0.83
Intra-arterial hepatic chemotherapy combined with continuous infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma. Ann Oncol (2002) 0.82
Extent of resection and outcome after curative resection for intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am (2002) 0.82
Prevention of bile duct cancer in primary sclerosing cholangitis. Ann Oncol (1999) 0.77
Mucobilia: the clinical spectrum, diagnosis and treatment. J Gastroenterol Hepatol (1998) 0.77
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet (2012) 6.83
MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol (2012) 2.03
Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology (2010) 1.77
Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth? Ann Surg Oncol (2011) 1.65
Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol (2012) 1.63
Lifestyle risk factors for intrahepatic stone: findings from a case-control study in an endemic area, Taiwan. J Gastroenterol Hepatol (2007) 1.41
Primary angiosarcoma of the spleen. J Surg Oncol (2005) 1.37
Successful laparoscopic management for cholecystoenteric fistula. World J Gastroenterol (2006) 1.36
Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg (2006) 1.36
IgG4-positive plasma cells in cutaneous Rosai-Dorfman disease: an additional immunohistochemical feature and possible relationship to IgG4-related sclerosing disease. J Cutan Pathol (2009) 1.34
Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood (2008) 1.28
A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS One (2011) 1.27
Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog (2010) 1.27
Management and outcome of bleeding pseudoaneurysm associated with chronic pancreatitis. BMC Gastroenterol (2006) 1.23
Symptomatic adult annular pancreas. J Clin Gastroenterol (2003) 1.17
Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. BMC Gastroenterol (2006) 1.14
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14
Clinicopathological analysis of cystic duct carcinoma. Hepatogastroenterology (2005) 1.13
Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis. Am J Surg (2012) 1.13
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma. PLoS One (2012) 1.10
Correct diagnosis and successful treatment for pericardial effusion due to toothpick injury: a case report and literature review. World J Gastroenterol (2007) 1.10
Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int (2010) 1.10
Regulatory T cells in transplantation. Semin Immunol (2006) 1.10
Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol (2004) 1.09
Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest (2004) 1.09
Spontaneous rupture of solid pseudopapillary neoplasm of the pancreas during pregnancy. Obstet Gynecol (2013) 1.09
Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells. Trends Immunol (2005) 1.07
Adenosquamous carcinoma of the pancreas. Digestion (2005) 1.05
Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Hepatology (2005) 1.05
Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients. Oncologist (2011) 1.04
Surgical management of gallbladder sarcomatoid carcinoma. World J Gastroenterol (2009) 1.04
Hepatocellular carcinoma and vitamin D: a review. J Gastroenterol Hepatol (2011) 1.03
Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg (2006) 1.03
Epicardial ablation of rotors suppresses inducibility of acetylcholine-induced atrial fibrillation in left pulmonary vein-left atrium preparations in a beagle heart failure model. J Am Coll Cardiol (2011) 1.03
The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cells. J Immunol (2012) 1.03
Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res (2012) 1.03
Breast metastasis from uterine leiomyosarcoma: a case report. Arch Gynecol Obstet (2002) 1.03
Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma. World J Surg Oncol (2008) 1.03
Standard radical gastrectomy in octogenarians and nonagenarians with gastric cancer: are short-term surgical results and long-term survival substantial? J Gastrointest Surg (2012) 1.02
CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection. BMC Cancer (2009) 1.02
Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol (2009) 1.00
Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg (2003) 1.00
Timing of mortality in severe acute pancreatitis: experience from 643 patients. World J Gastroenterol (2007) 1.00
Clinicopathological study of solid and pseudopapillary tumor of pancreas: emphasis on magnetic resonance imaging findings. World J Gastroenterol (2007) 0.99
Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Hum Pathol (2002) 0.98
Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin. Ann Surg Oncol (2011) 0.98
Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger. J Surg Oncol (2012) 0.97
Laparoscopic resection of gastrointestinal stromal tumors: safe, efficient, and comparable oncologic outcomes. J Laparoendosc Adv Surg Tech A (2012) 0.96
Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma. Oncotarget (2014) 0.95
Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. BMC Cancer (2011) 0.95
Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection. PLoS One (2011) 0.95
Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance. World J Gastroenterol (2011) 0.94
Chromogranin A is a reliable biomarker for gastroenteropancreatic neuroendocrine tumors in an Asian population of patients. Neuroendocrinology (2012) 0.94
Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture--a case report. World J Surg Oncol (2012) 0.94
Modified endoscopic submucosal dissection with enucleation for treatment of gastric subepithelial tumors originating from the muscularis propria layer. BMC Gastroenterol (2012) 0.94
N3 subclassification incorporated into the final pathologic staging of gastric cancer: a modified system based on current AJCC staging. Medicine (Baltimore) (2015) 0.94
High-frequency Alu-mediated genomic recombination/deletion within the caspase-activated DNase gene in human hepatoma. Oncogene (2005) 0.93
Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol (2009) 0.93
Local anesthesia with ropivacaine for patients undergoing laparoscopic cholecystectomy. World J Gastroenterol (2009) 0.93
19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells. Steroids (2011) 0.92
Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells. Urol Oncol (2011) 0.92
Balloon-assisted enteroscopy with prophylactic polypectomy for Peutz-Jeghers syndrome: experience in Taiwan. Dig Dis Sci (2010) 0.92
Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung. Am J Clin Pathol (2009) 0.91
Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1. Lab Invest (2005) 0.91
Colonoscopic feature of primary adenocarcinoma of the appendix:. Intern Med (2008) 0.91
Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2. Cancer Lett (2005) 0.90
Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Arch Surg (2005) 0.90
Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. Cell Cycle (2013) 0.89
Early signet ring cell gastric cancer. Dig Dis Sci (2010) 0.89
Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer. Medicine (Baltimore) (2015) 0.89
Does Epstein-Barr virus play a role in lymphoepithelioma-like carcinoma of the uterine cervix? Int J Gynecol Pathol (2009) 0.89
Endo-GIA for ligation of dilated cystic duct during laparoscopic cholecystectomy: an alternative, novel, and easy method. J Laparoendosc Adv Surg Tech A (2004) 0.89
Small-cell neuroendocrine carcinoma of the nasopharynx: report of a rare case lacking association with Epstein-Barr virus. Int J Surg Pathol (2008) 0.88
Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes. J Clin Virol (2013) 0.88
Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection. Hepatol Res (2009) 0.88
Follicular dendritic cell sarcoma mimicking giant cell carcinoma of the pancreas. Pathol Int (2006) 0.88
Multifocal intraductal papillary mucinous neoplasm of the pancreas--a case report. World J Gastroenterol (2009) 0.88
K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol (2012) 0.88
Effector/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity. J Immunol (2009) 0.88
Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas. Ann Surg Oncol (2011) 0.87